Passive

Invesco Pharmaceuticals ETF

The Invesco Pharmaceuticals ETF (the “Fund”) seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical Intellidex® Index (the “Underlying Index”).

$78.07

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Pharmaceuticals ETF PJP
Fund Size
$324 Million
Dividend
1.2%
Fees
-
Total Stock Market Index Fund VTI
Fund Size
$1.78 Trillion
Dividend
1.4%
Fees
0.03%
500 Index Fund VOO
Fund Size
$1.35 Trillion
Dividend
1.4%
Fees
0.03%
Core S&P 500 ETF IVV
Fund Size
$590 Billion
Dividend
1.5%
Fees
0.03%
Total International Stock Index Fund VXUS
Fund Size
$447 Billion
Dividend
3.2%
Fees
0.07%
View 1303 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $137 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.43 %
Beta Indicates the relationship between the price performance of a share and the market. 0.5469
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 35.91
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -85.69
Profitable Companies 73
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 807.33
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 5.27
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 9.21
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT 25.49
Enterprise Value to Revenue Enterprise value divided by revenue 69.09
Total Debt to Enterprise Value Total debt divided by enterprise value 0.19
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.4759
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -1218.27%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. 21.71%
Return on Assets Indicates a company's profitability in relation to its total assets. 4.34%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 9.85%

Industries

Healthcare 85.7%
Finance 2.9%
N/A 11.4%

Market cap

Micro Cap 0%
Small Cap 20%
Mid Cap 21%
Large Cap 29%
Mega Cap 30%

35 Investments

P/E-Ratio
Total Investment
Weight
Invesco Private Prime Fund logo

Invesco Private Prime Fund

P/E-Ratio
n/a
Total Investment
$42.2 Million
Weight
15.9%
Invesco Private Government Fund logo

Invesco Private Government Fund

P/E-Ratio
n/a
Total Investment
$16.2 Million
Weight
6.1%
Abbott Laboratories logo

ABT - Manufacturing

Abbott Laboratories

P/E-Ratio
16.9
Total Investment
$14.4 Million
Weight
5.4%
Eli Lilly and Co. logo

LLY - Manufacturing

Eli Lilly and Co.

P/E-Ratio
71.7
Total Investment
$14.3 Million
Weight
5.4%
AbbVie Inc. logo

ABBV - Manufacturing

AbbVie Inc.

P/E-Ratio
71.4
Total Investment
$13.8 Million
Weight
5.2%
Pfizer Inc. logo

PFE - Manufacturing

Pfizer Inc.

P/E-Ratio
15.7
Total Investment
$13.5 Million
Weight
5.1%
Bristol-Myers Squibb Co. logo

BMY - Manufacturing

Bristol-Myers Squibb Co.

P/E-Ratio
-16.7
Total Investment
$13.3 Million
Weight
5.0%
Merck & Co., Inc. logo

MRK - Manufacturing

Merck & Co., Inc.

P/E-Ratio
11.6
Total Investment
$13 Million
Weight
4.9%
Johnson & Johnson logo

JNJ - Manufacturing

Johnson & Johnson

P/E-Ratio
26.9
Total Investment
$13 Million
Weight
4.9%
Amgen Inc. logo

AMGN - Manufacturing

Amgen Inc.

P/E-Ratio
36.6
Total Investment
$12.9 Million
Weight
4.9%
Liquidia Corp. logo

LQDA - Manufacturing

Liquidia Corp.

P/E-Ratio
-8.3
Total Investment
$9.18 Million
Weight
3.5%
Corcept Therapeutics Inc. logo

CORT - Manufacturing

Corcept Therapeutics Inc.

P/E-Ratio
45.7
Total Investment
$8.23 Million
Weight
3.1%
Travere Therapeutics, Inc. logo

TVTX - Manufacturing

Travere Therapeutics, Inc.

P/E-Ratio
-3.9
Total Investment
$8.17 Million
Weight
3.1%
Harmony Biosciences Holdings, Inc. logo

HRMY - Manufacturing

Harmony Biosciences Holdings, Inc.

P/E-Ratio
17.1
Total Investment
$8.1 Million
Weight
3.1%
Tarsus Pharmaceuticals, Inc. logo

TARS - Manufacturing

Tarsus Pharmaceuticals, Inc.

P/E-Ratio
-8.5
Total Investment
$8.07 Million
Weight
3.0%
Gilead Sciences, Inc. logo

GILD - Manufacturing

Gilead Sciences, Inc.

P/E-Ratio
271.8
Total Investment
$7.79 Million
Weight
2.9%
Supernus Pharmaceuticals, Inc. logo

SUPN - Manufacturing

Supernus Pharmaceuticals, Inc.

P/E-Ratio
22.9
Total Investment
$7.71 Million
Weight
2.9%
Collegium Pharmaceutical, Inc. logo

COLL - Manufacturing

Collegium Pharmaceutical, Inc.

P/E-Ratio
12.5
Total Investment
$7.57 Million
Weight
2.9%
Jazz Pharmaceuticals PLC logo

JAZZ - Manufacturing

Jazz Pharmaceuticals PLC

P/E-Ratio
11.1
Total Investment
$7.26 Million
Weight
2.7%
ANI Pharmaceuticals, Inc. logo

ANIP - Manufacturing

ANI Pharmaceuticals, Inc.

P/E-Ratio
-72.7
Total Investment
$7.26 Million
Weight
2.7%
Amneal Pharmaceuticals, Inc. logo

AMRX - Manufacturing

Amneal Pharmaceuticals, Inc.

P/E-Ratio
-19.5
Total Investment
$7.15 Million
Weight
2.7%
Innoviva, Inc. logo

INVA - Manufacturing

Innoviva, Inc.

P/E-Ratio
49.0
Total Investment
$7.05 Million
Weight
2.7%
Ligand Pharmaceuticals Inc. logo

LGND - Manufacturing

Ligand Pharmaceuticals Inc.

P/E-Ratio
-494.0
Total Investment
$7.01 Million
Weight
2.6%
United Therapeutics Corp. logo

UTHR - Manufacturing

United Therapeutics Corp.

P/E-Ratio
10.6
Total Investment
$6.91 Million
Weight
2.6%
Biogen Inc. logo

BIIB - Manufacturing

Biogen Inc.

P/E-Ratio
10.6
Total Investment
$6.58 Million
Weight
2.5%